CD274 and neoplasm: These studies are also important because it is expected that tumors with high PD‐L1 expression, or other inhibitory checkpoints ligands, will be the best protected against the endogenous immune response, while patients with such tumor characteristics are also believed to be good candidates for immunotherapy, with better efficacy of immune checkpoint blockade, and reinvigoration of the immune response.